MAIA Biotechnology, Inc. (MAIA) Ownership

$1.73

south_east
-$0.08 (-4.17%)
Day's range
$1.65
Day's range
$1.83

MAIA Biotechnology, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VANGUARD GROUP INC 11/07/2025 1.10 M $1.70 M   -3.30% 3.64%
CENTRIC WEALTH MANAGEMENT 11/04/2025 574.90 K $712.87 K   0.26% 1.90%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 271.06 K $417.53 K   22.00% 0.89%
MARSHALL WACE, LLP 11/13/2025 110.47 K $170.12 K   583.37% 0.36%
BLACKROCK, INC. 11/12/2025 104.86 K $161.48 K   1.54% 0.35%
STATE STREET CORP 11/14/2025 75.55 K $116.35 K   0.00% 0.25%
NORTHERN TRUST CORP 11/14/2025 39.03 K $60.11 K   0.00% 0.13%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 11/14/2025 36.00 K $55.44 K   0.00% 0.12%
CENTERPOINT ADVISORY GROUP 11/04/2025 15.73 K $24.22 K   0.00% 0.05%
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 10/29/2025 14.80 K $26.49 K   0.00% 0.05%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 11.62 K $17.89 K   100.00% 0.04%
ADVISOR GROUP HOLDINGS, INC. 11/14/2025 8.33 K $12.83 K   0.00% 0.03%
TOWER RESEARCH CAPITAL LLC (TRC) 11/14/2025 4.03 K $6.20 K   117.98% 0.01%
CURIO WEALTH, LLC 11/13/2025 2.00 K $3.08 K   100.00% 0.01%
MORGAN STANLEY 11/14/2025 832 $1.28 K   -83.67% 0.00%
MAI CAPITAL MANAGEMENT 11/10/2025 675 $1.04 K   0.00% 0.00%
CITIGROUP INC 11/10/2025 530 $816   100.00% 0.00%
JONES FINANCIAL COMPANIES LLLP 11/04/2025 228 $369   0.00% 0.00%
BANK OF AMERICA CORP /DE/ 11/14/2025 29 $45   -87.45% 0.00%
JPMORGAN CHASE & CO 11/26/2025 0 $0   -100.00% 0.00%
RAYMOND JAMES FINANCIAL INC 11/14/2025 0 $0   -100.00% 0.00%
JANE STREET GROUP, LLC 11/14/2025 0 $0   -100.00% 0.00%
UBS GROUP AG 11/13/2025 0 $0   -100.00% 0.00%

MAIA Biotechnology, Inc. institutional Ownership - FAQ's

During the previous two years, 25 institutional investors and hedge funds held shares of MAIA Biotechnology, Inc.. The most heavily invested institutionals were:

VANGUARD GROUP INC: 1.1 M

Centric Wealth Management: 574,898

GEODE CAPITAL MANAGEMENT, LLC: 271,056

MARSHALL WACE, LLP: 110,467

BlackRock, Inc.: 104,857

STATE STREET CORP: 75,550

7.83% of MAIA Biotechnology, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 2.45 M shares in the last 24 months. This purchase volume represents approximately $4.23 M in transactions.